• Science & Technology

2017 Nobel Prize in Chemistry: how making microscopes cool is helping cancer research

This year's Nobel Prize in Chemistry was awarded to the developers of cool microscopes. And the tech is boosting cancer research. This year's Nobel Prize in Chemistry was awarded to the developers of cool microscopes. And the tech is boosting cancer research.

5 October 2017

• Science & Technology

Cancer blood tests and learning from HIV – our latest Pioneer Awards

Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets. Drawing similarities between how the immune system reacts to lung cancer and HIV could uncover potential new drug targets.

29 September 2017

• Health & Medicine
• Personal Stories

Taking part in clinical trials – Tommy’s story

In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial. In 2012, Tommy Brennan was diagnosed with bladder cancer. Here, he shares his story and his experience of joining a Cancer Research UK-funded clinical trial.

26 September 2017

• Science & Technology
• Health & Medicine

Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease. A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

26 September 2017

• Health & Medicine

Pelvis-targeting radiotherapy safe for prostate cancer patients

A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study. A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.

26 September 2017

• Health & Medicine

Smoking quit rates highest in 10 years

New data by UCL suggest success rates for quitting smoking are at their highest level for a decade. New data by UCL suggest success rates for quitting smoking are at their highest level for a decade.

21 September 2017

• Health & Medicine

Immunotherapy and targeted drugs could stop some melanomas from returning

Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease. Two clinical trials have found that existing treatments for advanced melanoma could stop the cancer returning in some people with earlier stage disease.

12 September 2017

• Health & Medicine
• Science & Technology

News digest – Brexit, viral treatments, alcohol, and… prostate cancer screening?

In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer. In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.

9 September 2017

• Health & Medicine

Two treatments for advanced prostate cancer bring equal benefits

Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer. Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.

8 September 2017

• Health & Medicine

Viruses may boost immunotherapy success

Viruses may improve the success rate of immunotherapy treatments, according to two new studies. Viruses may improve the success rate of immunotherapy treatments, according to two new studies.

8 September 2017

• Health & Medicine

Targeted drug helps keep some advanced ovarian cancers at bay

Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening. Unpublished trial results have found that a drug which targets genetic vulnerabilities in tumour cells can delay some advanced ovarian cancers from worsening.

8 September 2017